viewAbzena PLC

Abzena CEO on the potential for acquisitions and reaching profitability

John Burt, the chief executive of Abzena (LON:ABZA), discusses the company’s business model, the busy period of newsflow ahead, and the potential for acquisitions.

While profitability may be a few years away yet, Burt says there are already a few products in the clinic that the company will be able to earn royalties from.

The company raised £20 million in last July’s IPO, which Burt says ‘gives a good platform for the future because our business model doesn’t require a lot of capital because we’re not funding clinical trials’.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Amundi Physical Gold ETC: Europe's cheapest ETC now trading on the London...

Amundi Physical Gold ETC's Ashley Fagan who's head of ETF, Indexing & Smart Beta Development for UK and Ireland introduces the product to Proactive London's Andrew Scott. She says they've seen a great deal of demand from European as well as UK investors and that's what lead them to list...

23 hours, 30 minutes ago

2 min read